Treatment of Myelofibrosis—Where Are We Now? Interview With Dr. Ronald Hoffman
Dr. Ronald Hoffman: Treatment of Myelofibrosis—Where Are We Now?
L Scott Zoeller
20110522
2011 Jun 22
OncologySTAT Editorial Team
Treatment of Myelofibrosis—Where Are We Now? Interview With Dr. Ronald Hoffman
OncologySTAT Editorial Team. 2011 Jun 22, L Scott Zoeller
Ronald Hoffman, MD, is Professor of Medicine, Hematology, and Medical Oncology and Professor of Gene and Cell Medicine, Mount Sinai School of Medicine, New York, NY. OncologySTAT: Dr. Hoffman, would you talk about some of the challenges associated with treatment for patients with myelofibrosis? What options are currently available to alleviate constitutional symptoms and anemia?Dr. Hoffman: Myelofibrosis is one of the Philadelphia chromosome–negative myeloproliferative neoplasms, which include polycythemia...